Publication | Open Access
MINI01.02: Response and Plasma Genotyping from Phase I/II Trial of Ensartinib (X-396) in Patients (pts) with ALK+ NSCLC
10
Citations
0
References
2016
Year
No additional data available for this publication yet. Check back later!